miR-141 as potential suppressor of β-catenin in breast cancer

Tumor Biology

Volumn 36, Issue 12, 2015, Pages 9895-9901

  Abedi, Nairi ^a   Mohammadi Yeganeh, Samira ^b,c   Koochaki, Ameneh ^b,c   Karami, Fariba ^a   Paryan, Mahdi ^d  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d PASTEUR INSTITUTE OF IRAN   (Iran)

Author keywords

CTNNB1 gene; Luciferase assay; miRNA; Triple negative breast cancer; Wnt signaling

Indexed keywords

BETA CATENIN; MICRORNA 141; MICRORNA; MIRN141 MICRORNA, HUMAN;

3' UNTRANSLATED REGION; ARTICLE; BIOINFORMATICS; BREAST CARCINOGENESIS; CONTROLLED STUDY; CTNNB1 GENE; DOWN REGULATION; GENE EXPRESSION; LUCIFERASE ASSAY; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; TRIPLE NEGATIVE BREAST CANCER; WNT SIGNALING PATHWAY; BIOSYNTHESIS; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; PATHOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

BETA CATENIN; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; SIGNAL TRANSDUCTION; TRIPLE NEGATIVE BREAST NEOPLASMS;

EID: 84951320600     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-015-3738-y     Document Type: Article

References (28)

1. Singh R, Mo Y-Y. Role of microRNAs in breast cancer. Cancer Biol Ther. 2013;14(3):201–12.
2. Shah NR, Chen H. MicroRNAs in pathogenesis of breast cancer: implications in diagnosis and treatment. World J Clin Oncol. 2014;5(2):48.
3. Avery-Kiejda KA et al. Decreased expression of key tumour suppressor microRNAs is associated with lymph node metastases in triple negative breast cancer. BMC Cancer. 2014;14(1):51.
4. Gasparini P et al. microRNA expression profiling identifies a four microRNA signature as a novel diagnostic and prognostic biomarker in triple negative breast cancers. Oncotarget. 2014;5(5):1174.
5. Schneider BP et al. Triple-negative breast cancer: risk factors to potential targets. Clin Cancer Res. 2008;14(24):8010–8.
6. Kamdje AHN et al. Signaling pathways in breast cancer: therapeutic targeting of the microenvironment. Cell Signal. 2014;26(12):2843–56.
7. Howe LR, Brown AM. Wnt signaling and breast cancer. Cancer Biol Ther. 2004;3(1):36–41.
8. Chu EY et al. Canonical WNT signaling promotes mammary placode development and is essential for initiation of mammary gland morphogenesis. Development. 2004;131(19):4819–29.
9. Khramtsov AI et al. Wnt/β-catenin pathway activation is enriched in basal-like breast cancers and predicts poor outcome. Am J Pathol. 2010;176(6):2911–20.
10. Hatsell S et al. β-Catenin and Tcfs in mammary development and cancer. J Mammary Gland Biol Neoplasia. 2003;8(2):145–58.
11. Cai J et al. MicroRNA-374a activates Wnt/β-catenin signaling to promote breast cancer metastasis. J Clin Invest. 2013;123(2):566.
12. Kim VN, Han J, Siomi MC. Biogenesis of small RNAs in animals. Nat Rev Mol Cell Biol. 2009;10(2):126–39.
13. Cai Y et al. A brief review on the mechanisms of miRNA regulation. Genomics Proteomics Bioinformatics. 2009;7(4):147–54.
14. Winter J et al. Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat Cell Biol. 2009;11(3):228–34.
15. Calin GA, Croce CM. MicroRNA-cancer connection: the beginning of a new tale. Cancer Res. 2006;66(15):7390–4.
16. Nana-Sinkam SP, Fabbri M, Croce CM. MicroRNAs in cancer: personalizing diagnosis and therapy. Ann N Y Acad Sci. 2010;1210(1):25–33.
17. Faryal R. Role of miRNAs in breast cancer. Asian Pac J Cancer Prev. 2011;12:3175–80.
18. Mendes N, Freitas AT, Sagot M-F. Current tools for the identification of miRNA genes and their targets. Nucleic Acids Res. 2009;37(8):2419–33.
19. Al-Rajab M. and J. Lu, Bioinformatics: an overview for cancer research. 2012.
20. Mount, D.W., Sequence and genome analysis. Bioinformatics: Cold Spring Harbour Laboratory Press: Cold Spring Harbour. 2004; 2.
21. Dull T et al. A third-generation lentivirus vector with a conditional packaging system. J Virol. 1998;72(11):8463–71.
22. Huang K et al. MicroRNA roles in beta-catenin pathway. Mol Cancer. 2010;9(1):252.
23. Zhao H et al. A pilot study of circulating miRNAs as potential biomarkers of early stage breast cancer. PLoS One. 2010;5(10), e13735.
24. Xin F et al. Computational analysis of microRNA profiles and their target genes suggests significant involvement in breast cancer antiestrogen resistance. Bioinformatics. 2009;25(4):430–4.
25. Wang C et al. MicroRNA-203 suppresses cell proliferation and migration by targeting BIRC5 and LASP1 in human triple-negative breast cancer cells. J Exp Clin Cancer Res. 2012;31(1):58.
26. Mohammadi-Yeganeh S et al. Development of a robust, low cost stem-loop real-time quantification PCR technique for miRNA expression analysis. Mol Biol Rep. 2013;40(5):3665–74.
27. Bilir B, Kucuk O, Moreno CS. Wnt signaling blockage inhibits cell proliferation and migration, and induces apoptosis in triple-negative breast cancer cells. J Transl Med. 2013;11(1):280.
28. Esau C et al. MicroRNA-143 regulates adipocyte differentiation. J Biol Chem. 2004;279(50):52361–5.